Trial Profile
Phase I-II Study Evaluating Combined Treatment of Cetuximab and Trastuzumab in Metastatic Pancreatic Cancer Patients Progressing After Gemcitabine Based Chemotherapy.(THERAPY)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 17 Apr 2019
Price :
$35
*
At a glance
- Drugs Trastuzumab (Primary) ; Cetuximab
- Indications Pancreatic cancer
- Focus Therapeutic Use
- Acronyms THERAPY
- 10 Apr 2019 Status changed from recruiting to completed.
- 24 Jun 2009 New trial record